Back
Bank Of China Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
63
BACHF
Bank Of China
Last Price:
$0.58
Seasonality Move:
1.83%
Sell
46
SRPT
Sarepta Therapeutics
Last Price:
$54.38
Seasonality Move:
15.14%
Buy
63
Bank Of China (BACHF)
is a Buy
Is Bank Of China a Buy, Sell or Hold?
-
The current Bank Of China [BACHF] share price is $0.58. The Score for BACHF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
BACHF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $54.43. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BACHF Stock Price Chart
What is Bank Of China's stock price today?
-
The Bank Of China share price today is $0.58The current trend is relatively stagnant and BACHF is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $54.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
BACHF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 52.8 | Buy |
Chaikin Money Flow: | -11216 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.56 - 0.6) | Buy |
Bollinger Bands (100): | (0.48 - 0.56) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.96 | Sell |
Relative Strength Index (14 RSI): | 19.8 | Sell |
Chaikin Money Flow: | -4277485 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.24 - 101.14) | Sell |
Bollinger Bands (100): | (90.97 - 127.95) | Sell |
BACHF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.58 | Buy |
20-day SMA: | 0.58 | Buy |
50-day SMA: | 0.56 | Buy |
200-day SMA: | 0.49 | Buy |
8-day EMA: | 0.58 | Sell |
20-day EMA: | 0.58 | Buy |
50-day EMA: | 0.56 | Buy |
200-day EMA: | 0.5 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.54 | Sell |
20-day SMA: | 78.39 | Sell |
50-day SMA: | 97.73 | Sell |
200-day SMA: | 122.38 | Sell |
8-day EMA: | 63.87 | Sell |
20-day EMA: | 75.73 | Sell |
50-day EMA: | 92.2 | Sell |
200-day EMA: | 113.44 | Sell |
Bank Of China Earnings Growth & BACHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.39 per share, a decrease next quarter of $0.51 per share, an increase this year of $5.17 per share, and an increase next year of $5.45 per share.
Bank Of China Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |